
Joseph Gridley

Jennifer Harkins Garone

Bart Maene

Issy Gordon

Heloïse Nogues

Alia El-Yassir

Robert G. Bristow
Robert Bristow completed his PhD in Medical Biophysics and Residency in Radiation Oncology at the University of Toronto with post-graduate fellowships at Erasmus University Rotterdam, MD Anderson Cancer Centre and Massachusetts General Hospital.
Bristow joined the University of Manchester as Director of the Manchester Cancer Research Centre (MCRC) in August 2017 to develop a new cancer strategy. His research focusses on the prostate cancer genome and tumour microenvironment hypoxic tumour cell characterisation by understanding role of hypoxia in driving genetic instability and the changes in sporadic and hereditary (e.g. BRCA2) prostate cancer genomes during cancer aggression.
He co-Leads the Manchester arm of the International Alliance for Cancer Early Detection (ACED), with an interest in signatures that predict aggression in men with sporadic and hereditary prostate cancer. Rob also sits on the Alliance Executive Board (AEB).